|
⚲
|
| Keyboard |
| Sevigny Jeffrey
✚
|
|
|---|---|
| CIK # | 0001778483 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001778483] | |
| 4 | [0001778483] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Rapport Therapeutics Inc | |
| Sevigny Jeffrey | |
| Acumen Pharmaceuticals Inc | |
| Prevail Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rapport Therapeutics Inc RAPP
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 130,000 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Stock Option (Right to Buy) · derivative
|
2025-04-01 | Grant | 300,000 | $0.00 | |
|
Acumen Pharmaceuticals Inc ABOS
Stock Option (right to buy) · derivative
|
2022-06-15 | Grant | 25,000 | $0.00 | |
|
Acumen Pharmaceuticals Inc ABOS
Stock Option (Right to Buy) · derivative
|
2021-06-30 | Grant | 34,000 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 400,342 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 122,439 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2021-01-22 | Disposed to issuer | 89,000 | $0.00 | |
|
Prevail Therapeutics Inc PRVL
Stock Option (Right to Buy) · derivative
|
2020-02-19 | Grant | 89,000 | $0.00 |